XORTX Therapeutics Inc. (NASDAQ:XRTX – Get Free Report) was the recipient of a large decline in short interest in May. As of May 29th, there was short interest totaling 22,256 shares, a decline of 58.5% from the May 14th total of 53,649 shares. Currently, 1.4% of the company’s stock are sold short. Based on an average daily volume of 36,983 shares, the short-interest ratio is currently 0.6 days.
Institutional Trading of XORTX Therapeutics
An institutional investor recently raised its position in XORTX Therapeutics stock. Citadel Advisors LLC increased its holdings in shares of XORTX Therapeutics Inc. (NASDAQ:XRTX – Free Report) by 124.4% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 86,326 shares of the technology company’s stock after acquiring an additional 47,858 shares during the quarter. Citadel Advisors LLC owned approximately 1.24% of XORTX Therapeutics worth $70,000 as of its most recent SEC filing. 0.23% of the stock is owned by institutional investors and hedge funds.
Analysts Set New Price Targets
Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of XORTX Therapeutics in a report on Friday, March 27th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat, the stock currently has a consensus rating of “Sell”.
XORTX Therapeutics Stock Performance
Shares of XRTX opened at $2.13 on Friday. XORTX Therapeutics has a 52 week low of $1.73 and a 52 week high of $7.05. The stock has a 50 day moving average price of $2.40 and a two-hundred day moving average price of $2.51. The firm has a market capitalization of $3.68 million, a P/E ratio of -0.81 and a beta of 0.74.
XORTX Therapeutics (NASDAQ:XRTX – Get Free Report) last issued its quarterly earnings results on Friday, May 15th. The technology company reported ($0.58) EPS for the quarter.
XORTX Therapeutics Company Profile
Xyratex Ltd (Xyratex) is a provider of data storage technology, including modular solutions for the enterprise data storage industry and hard disk drive (HDD) capital equipment for the HDD industry. Xyratex operates in two segments: Networked Storage Solutions (NSS) and Storage Infrastructure (SI). Its NSS products are primarily HDD based data storage subsystems and solutions, which it provides to original equipment manufacturers. Its SI products consist of HDD manufacturing process equipment, which it sells directly to manufacturers of HDDs and their component suppliers.
Featured Articles
- Five stocks we like better than XORTX Therapeutics
- Microsoft Just Gave Investors 3 Dates They Can’t Afford to Ignore
- NVIDIA’s Outlook Gains Momentum: Stock Price to Follow
- The World Cup Is Coming—These 3 Stocks Could Cash In
- Spotify’s “North Star” Outlook Was Music to Investors Ears
Receive News & Ratings for XORTX Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XORTX Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
